Stockscreener 앱 받기
12.08
0.58%
0.07
시간 외 거래:
11.78
-0.30
-2.48%
전일 마감가:
$12.01
열려 있는:
$11.89
하루 거래량:
1.00M
Relative Volume:
0.53
시가총액:
$1.59B
수익:
$260.11M
순이익/손실:
$60.64M
주가수익비율:
28.09
EPS:
0.43
순현금흐름:
$92.29M
1주 성능:
-0.08%
1개월 성능:
+40.14%
6개월 성능:
+52.33%
1년 성능:
+83.31%
1일 변동 폭
$11.74
$12.15
1주일 범위
$11.74
$12.53
52주 변동 폭
$6.42
$12.53
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
명칭
Aurinia Pharmaceuticals Inc
전화
250-744-2487
주소
#140, 14315 - 118 AVENUE, EDMONTON, BC
AUPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AUPH
Aurinia Pharmaceuticals Inc
|
12.08 | 1.61B | 260.11M | 60.64M | 92.29M | 0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.46 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
598.16 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
467.55 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
663.73 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.97 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-30 | 재개 | H.C. Wainwright | Buy |
| 2022-11-04 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-05-05 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-12-10 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-10-28 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-01-25 | 재확인 | H.C. Wainwright | Buy |
| 2020-11-03 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-17 | 개시 | BTIG Research | Buy |
| 2020-05-05 | 개시 | Cowen | Outperform |
| 2020-01-10 | 개시 | Jefferies | Buy |
| 2019-12-16 | 재확인 | H.C. Wainwright | Buy |
| 2018-03-16 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-02-08 | 개시 | RBC Capital Mkts | Outperform |
| 2017-10-30 | 재확인 | H.C. Wainwright | Buy |
| 2017-05-18 | 재확인 | H.C. Wainwright | Buy |
| 2017-04-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-03-22 | 재확인 | FBR & Co. | Outperform |
| 2016-12-30 | 재확인 | H.C. Wainwright | Buy |
| 2016-08-17 | 재확인 | H.C. Wainwright | Buy |
| 2016-06-30 | 개시 | H.C. Wainwright | Buy |
| 2015-05-08 | 개시 | MLV & Co | Buy |
모두보기
Aurinia Pharmaceuticals Inc 주식(AUPH)의 최신 뉴스
Published on: 2025-08-21 04:00:48 - newsyoung.net
Aurinia Pharmaceuticals Reports Strong Q2 2025 Financial Results and Expands Share Repurchase Plan - MSN
Why is Aurinia Pharmaceuticals Inc. stock going down2025 Growth vs Value & Capital Protection Trading Alerts - thegnnews.com
There's No Escaping Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) Muted Revenues Despite A 29% Share Price Rise - 富途牛牛
Aurinia Pharmaceuticals stock hits 52-week high at 11.81 USD - Investing.com
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2025 Earnings Call Transcript - MSN
Can machine learning forecast Aurinia Pharmaceuticals Inc. recoveryShort Squeeze Opportunities with Indicators - Newser
Zurcher Kantonalbank Zurich Cantonalbank Acquires 8,390 Shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) - Defense World
Full technical analysis of Aurinia Pharmaceuticals Inc. stockFree Early Entry Tips With Low Risk Zone - Newser
What data driven models say about Aurinia Pharmaceuticals Inc.’s futureFree Expert Verified Stock Trade Ideas - Newser
Will Aurinia Pharmaceuticals Inc. stock go up soonHigh Conviction Stock Long-Term Summary - Newser
Is Aurinia Pharmaceuticals Inc. stock ready for a breakoutHigh Probability Trade Outcome Prediction - Newser
Aurinia Pharma: The Easiest Money May Have Been Made (Rating Downgrade) (NASDAQ:AUPH) - Seeking Alpha
Aurinia (AUPH) Q2 Revenue Jumps 22% - AOL.com
Day 6 of Gains Streak for Aurinia Pharmaceuticals Stock with 32% Return (vs. 30% YTD) [8/5/2025] - Trefis
Major Moves in Aurinia Pharmaceuticals Stock: Insider Trading Unveiled - TipRanks
Aurinia Pharma director Tang buys $13.59m in shares - Investing.com India
Aurinia Pharma director Tang buys $13.59m in shares By Investing.com - Investing.com Canada
Aurinia Pharmaceuticals Reaches Analyst Target Price - Nasdaq
Aurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 12-Month High on Analyst Upgrade - Defense World
Aurinia (AUPH) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Aurinia Pharmaceuticals stock hits 52-week high at 10.74 USD By Investing.com - Investing.com South Africa
Aurinia Pharmaceuticals stock hits 52-week high at 10.74 USD - Investing.com
Research Analysts Set Expectations for AUPH FY2026 Earnings - Defense World
Aurinia Pharmaceuticals: Strong Financial Performance and Promising Pipeline Drive Buy Rating - TipRanks
What is Leerink Partnrs’ Forecast for AUPH Q1 Earnings? - Defense World
What are the latest earnings results for Aurinia Pharmaceuticals Inc.Unprecedented profit potential - Jammu Links News
Published on: 2025-08-04 03:37:38 - Jammu Links News
What analysts say about Aurinia Pharmaceuticals Inc. stockCapitalize on emerging investment opportunities - Jammu Links News
What is the risk reward ratio of investing in Aurinia Pharmaceuticals Inc. stockBuild a portfolio that outperforms the market - Jammu Links News
Is it the right time to buy Aurinia Pharmaceuticals Inc. stockAchieve superior capital gains with smart trades - Jammu Links News
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Just Beat EPS By 9.1%: Here's What Analysts Are Forecasting For This Year - Yahoo Finance
Aurinia raises 2025 revenue outlook to $270M as LUPKYNIS accelerates market penetration - MSN
What catalysts could drive Aurinia Pharmaceuticals Inc. stock higher in 2025Unlock rapid growth potential in your portfolio - Jammu Links News
What drives Aurinia Pharmaceuticals Inc. stock priceFree Stock Market Mentorship - Jammu Links News
Should I hold or sell Aurinia Pharmaceuticals Inc. stock in 2025Free Investment Portfolio Suggestions - Jammu Links News
Aurinia Pharmaceuticals Reports Q2 EPS Beat, Analysts Raise 2025 Estimates - AInvest
What are the technical indicators suggesting about Aurinia Pharmaceuticals Inc.Rapid growth opportunities - Jammu Links News
What is Aurinia Pharmaceuticals Inc. company’s growth strategyFastest-growing stock picks - Jammu Links News
How does Aurinia Pharmaceuticals Inc. generate profit in a changing economyRetirement Planning Forecasts For Consistent Profits - jammulinksnews.com
Aurinia Pharmaceuticals (AUPH): A High-Growth Biopharma Play with Strong Earnings Momentum and Strategic Pipeline Expansion - AInvest
Aurinia Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations - uk.finance.yahoo.com
Published on: 2025-08-02 11:34:23 - beatles.ru
Aurinia Pharmaceuticals (NASDAQ:AUPH) Trading 6.1% Higher After Analyst Upgrade - Defense World
Q2 Earnings Estimate for AUPH Issued By HC Wainwright - Defense World
Aurinia Pharmaceuticals Inc. Added to High Probability Setup ListTechnical Entry Strategy for Beginners Explained - metal.it
RBC Raises Price Target on Aurinia Pharmaceuticals to $9 From $8, Keeps Outperform, Speculative Risk - MarketScreener
Aurinia 2025 Q2 Earnings Robust Net Income Growth at 2879.6% - AInvest
Aurinia Pharmaceuticals Inc (AUPH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Aurinia Pharmaceuticals (NASDAQ:AUPH) Earns Buy Rating from HC Wainwright - Defense World
Equities Analysts Issue Forecasts for AUPH Q1 Earnings - Defense World
Aurinia Pharmaceuticals Inc (AUPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Aurinia Pharmaceuticals Inc 주식 (AUPH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| TANG KEVIN | Director |
Aug 05 '25 |
Buy |
11.68 |
200,000 |
2,336,000 |
11,329,500 |
| TANG KEVIN | Director |
Aug 04 '25 |
Buy |
11.34 |
100,000 |
1,134,000 |
11,129,500 |
| Keenan Greg | Chief Medical Officer |
Aug 01 '25 |
Sale |
10.50 |
20,000 |
210,000 |
133,484 |
| Keenan Greg | Chief Medical Officer |
Mar 07 '25 |
Sale |
8.23 |
8,305 |
68,350 |
153,484 |
| Greenleaf Peter | Chief Executive Officer |
Mar 03 '25 |
Sale |
8.00 |
195,593 |
1,564,744 |
1,953,892 |
| Greenleaf Peter | Chief Executive Officer |
Mar 04 '25 |
Sale |
7.92 |
164,947 |
1,306,380 |
1,788,945 |
| Keenan Greg | Chief Medical Officer |
Mar 03 '25 |
Sale |
8.00 |
12,239 |
97,912 |
161,789 |
| Miller Joseph M | Chief Financial Officer |
Mar 03 '25 |
Sale |
8.00 |
61,859 |
494,872 |
633,515 |
| Miller Joseph M | Chief Financial Officer |
Mar 04 '25 |
Sale |
7.92 |
56,154 |
444,740 |
577,361 |
| Robertson Stephen P. | EVP, General Counsel |
Mar 03 '25 |
Sale |
8.00 |
64,872 |
518,976 |
566,883 |
1.55%
0.38%
자본화:
|
볼륨(24시간):